Short term outcomes after robot assisted and open cystectomy - A nation-wide population-based study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date:

Abstract

INTRODUCTION: We aimed to compare short term outcomes after robot assisted radical cystectomy (RARC) and open radical cystectomy (ORC) for urinary bladder cancer in a large population.

Authors

  • Oskar Bergengren
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: oskar.bergengren@surgsci.uu.se.
  • Alexej Belozerov
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Anna Bill-Axelson
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Hans Garmo
    Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden.
  • Oskar Hagberg
    Institution of Translational Medicine, Lund University, Malmö, Sweden.
  • Firas Aljabery
    Division of Urology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Truls Gårdmark
    Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
  • Staffan Jahnson
    Division of Urology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Tomas Jerlström
    Department of Urology, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Per-Uno Malmström
    Department of Surgical Sciences, Uppsala University, Uppsala 751 85, Sweden.
  • Amir Sherif
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
  • Viveka Ströck
    Department of Urology, Sahlgrenska University Hospital and Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Karin Söderkvist
    Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Anders Ullén
    Genitourinary Oncology and Urology Unit, Department of Oncology-Pathology, Karolinska Institutet, And Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Lars Holmberg
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Christel Häggström
    Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Public Health and Clinical Medicine, Northern Registry Centre, Umeå University, Sweden.
  • Fredrik Liedberg
    Institution of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.